Literature DB >> 32152117

Disruption of cellular proteostasis by H1N1 influenza A virus causes α-synuclein aggregation.

Rita Marreiros1, Andreas Müller-Schiffmann1, Svenja V Trossbach1, Ingrid Prikulis1, Sebastian Hänsch2, Stefanie Weidtkamp-Peters2, Ana Raquel Moreira3, Shriya Sahu3, Irina Soloviev3, Suganya Selvarajah3, Vishwanath R Lingappa3, Carsten Korth4.   

Abstract

Neurodegenerative diseases feature specific misfolded or misassembled proteins associated with neurotoxicity. The precise mechanisms by which protein aggregates first arise in the majority of sporadic cases have remained unclear. Likely, a first critical mass of misfolded proteins starts a vicious cycle of a prion-like expansion. We hypothesize that viruses, having evolved to hijack the host cellular machinery for catalyzing their replication, lead to profound disturbances of cellular proteostasis, resulting in such a critical mass of protein aggregates. Here, we investigated the effect of influenza virus (H1N1) strains on proteostasis of proteins associated with neurodegenerative diseases in Lund human mesencephalic dopaminergic cells in vitro and infection of Rag knockout mice in vivo. We demonstrate that acute H1N1 infection leads to the formation of α-synuclein and Disrupted-in-Schizophrenia 1 (DISC1) aggregates, but not of tau or TDP-43 aggregates, indicating a selective effect on proteostasis. Oseltamivir phosphate, an antiinfluenza drug, prevented H1N1-induced α-synuclein aggregation. As a cell pathobiological mechanism, we identified H1N1-induced blocking of autophagosome formation and inhibition of autophagic flux. In addition, α-synuclein aggregates appeared in infected cell populations connected to the olfactory bulbs following intranasal instillation of H1N1 in Rag knockout mice. We propose that H1N1 virus replication in neuronal cells can induce seeds of aggregated α-synuclein or DISC1 that may be able to initiate further detrimental downstream events and should thus be considered a risk factor in the pathogenesis of synucleinopathies or a subset of mental disorders. More generally, aberrant proteostasis induced by viruses may be an underappreciated factor in initiating protein misfolding.

Entities:  

Keywords:  DISC1; Parkinson’s disease; influenza; protein misfolding; α-synuclein

Mesh:

Substances:

Year:  2020        PMID: 32152117      PMCID: PMC7104400          DOI: 10.1073/pnas.1906466117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  80 in total

1.  Influenza RNA not detected in archival brain tissues from acute encephalitis lethargica cases or in postencephalitic Parkinson cases.

Authors:  S McCall; J M Henry; A H Reid; J K Taubenberger
Journal:  J Neuropathol Exp Neurol       Date:  2001-07       Impact factor: 3.685

Review 2.  In vivo aspects of protein folding and quality control.

Authors:  David Balchin; Manajit Hayer-Hartl; F Ulrich Hartl
Journal:  Science       Date:  2016-07-01       Impact factor: 47.728

Review 3.  Avian influenza and the brain--comments on the occasion of resurrection of the Spanish flu virus.

Authors:  Krister Kristensson
Journal:  Brain Res Bull       Date:  2005-12-21       Impact factor: 4.077

4.  Association of Parkinson's disease with infections and occupational exposure to possible vectors.

Authors:  M Anne Harris; Joseph K Tsui; Stephen A Marion; Hui Shen; Kay Teschke
Journal:  Mov Disord       Date:  2012-07-02       Impact factor: 10.338

5.  Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour.

Authors:  M Schwab; K Alitalo; K H Klempnauer; H E Varmus; J M Bishop; F Gilbert; G Brodeur; M Goldstein; J Trent
Journal:  Nature       Date:  1983 Sep 15-21       Impact factor: 49.962

6.  Invasion and persistence of the neuroadapted influenza virus A/WSN/33 in the mouse olfactory system.

Authors:  Fredrik Aronsson; Brita Robertson; Hans-Gustaf Ljunggren; Krister Kristensson
Journal:  Viral Immunol       Date:  2003       Impact factor: 2.257

7.  A population-based study of neurologic manifestations of severe influenza A(H1N1)pdm09 in California.

Authors:  Carol A Glaser; Kathleen Winter; Kara DuBray; Kathleen Harriman; Timothy M Uyeki; James Sejvar; Sabrina Gilliam; Janice K Louie
Journal:  Clin Infect Dis       Date:  2012-05-09       Impact factor: 9.079

8.  Subversion of cellular autophagosomal machinery by RNA viruses.

Authors:  William T Jackson; Thomas H Giddings; Matthew P Taylor; Sara Mulinyawe; Marlene Rabinovitch; Ron R Kopito; Karla Kirkegaard
Journal:  PLoS Biol       Date:  2005-04-26       Impact factor: 8.029

9.  Parkinson's disease or Parkinson symptoms following seasonal influenza.

Authors:  Stephen Toovey; Susan S Jick; Christoph R Meier
Journal:  Influenza Other Respir Viruses       Date:  2011-03-21       Impact factor: 4.380

Review 10.  Opportunistic intruders: how viruses orchestrate ER functions to infect cells.

Authors:  Madhu Sudhan Ravindran; Parikshit Bagchi; Corey Nathaniel Cunningham; Billy Tsai
Journal:  Nat Rev Microbiol       Date:  2016-06-06       Impact factor: 60.633

View more
  34 in total

Review 1.  Genetics of synucleins in neurodegenerative diseases.

Authors:  José Brás; Elizabeth Gibbons; Rita Guerreiro
Journal:  Acta Neuropathol       Date:  2020-08-01       Impact factor: 17.088

Review 2.  A Perspective on the Potential Involvement of Impaired Proteostasis in Neuropsychiatric Disorders.

Authors:  Kelvin K Hui; Ryo Endo; Akira Sawa; Motomasa Tanaka
Journal:  Biol Psychiatry       Date:  2021-09-14       Impact factor: 13.382

Review 3.  Molecular Mechanisms of SARS-CoV-2/COVID-19 Pathogenicity on the Central Nervous System: Bridging Experimental Probes to Clinical Evidence and Therapeutic Interventions.

Authors:  Stanislav A Groppa; Dumitru Ciolac; Carolina Duarte; Christopher Garcia; Daniela Gasnaș; Pavel Leahu; Daniela Efremova; Alexandru Gasnaș; Tatiana Bălănuță; Daniela Mîrzac; Alexandru Movila
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Frequency of Neurological Diseases After COVID-19, Influenza A/B and Bacterial Pneumonia.

Authors:  Pardis Zarifkar; Costanza Peinkhofer; Michael E Benros; Daniel Kondziella
Journal:  Front Neurol       Date:  2022-06-23       Impact factor: 4.086

5.  Likelihood of amyloid formation in COVID-19-induced ARDS.

Authors:  Nabodita Sinha; Ashwani K Thakur
Journal:  Trends Microbiol       Date:  2021-03-29       Impact factor: 17.079

Review 6.  Covid-19 Infection and Parkinsonism: Is There a Link?

Authors:  Rabia Bouali-Benazzouz; Abdelhamid Benazzouz
Journal:  Mov Disord       Date:  2021-06-08       Impact factor: 9.698

Review 7.  Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4.

Authors:  Carmela Conte
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

8.  The role of viruses in the pathogenesis of Parkinson's disease.

Authors:  José Fidel Baizabal-Carvallo; Marlene Alonso-Juarez
Journal:  Neural Regen Res       Date:  2021-06       Impact factor: 5.135

Review 9.  Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease.

Authors:  Luis M A Oliveira; Thomas Gasser; Robert Edwards; Markus Zweckstetter; Ronald Melki; Leonidas Stefanis; Hilal A Lashuel; David Sulzer; Kostas Vekrellis; Glenda M Halliday; Julianna J Tomlinson; Michael Schlossmacher; Poul Henning Jensen; Julia Schulze-Hentrich; Olaf Riess; Warren D Hirst; Omar El-Agnaf; Brit Mollenhauer; Peter Lansbury; Tiago F Outeiro
Journal:  NPJ Parkinsons Dis       Date:  2021-07-26

Review 10.  COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable?

Authors:  Luigi Ferini-Strambi; Maria Salsone
Journal:  J Neurol       Date:  2020-07-21       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.